Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

Your AAOA at the AMA

I want to urge you to consider membership in the AMA because your membership in…

read more

Fall Advocacy Update: USP 797, E/M Documentation and Payment

Revisions to USP Chapter 797 Open for Comment Since the United States Pharmacopeia (USP) released…

read more

Brief Update on the Final CY 2019 Physician Fee Schedule

On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/2018: Research Grant Cycle
Learn more

04/01/2019: 2019 Fellow Exam Application Deadline
Learn more

06/01/2019: Research Grant Cycle

06/7/19: Membership Application Deadline to be eligible for AAOA Member rate for the 2019 Basic Course

07/31/19: Membership Application Deadline to be voted in at the 2019 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2019 Annual Meeting
Learn more

EDUCATION

Codes/Guidelines

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

IFAR

IFAR Impact Factor: 2.135

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2019 Interactive Allergy & Rhinology Course
February 8-10, 2019 | Dallas, TX
Learn More and Register

2019 Basic Course in Allergy & Immunology
June 27-29 | Minneapolis, MN
Save the Date

2019 AAOA Annual Meeting
September 13-15 | New Orleans, LA
Save the Date

2019 Advanced Course in Allergy & Immunology
December 12-14 | Austin, TX
Save the Date

AAOA Clinical Insights
Learn More and Register

PATIENT CORNER

OTC Allergy Medications

There seem to be more and more medications available for allergy treatment that  you can now purchase over the counter.
The FDA is allowing previously prescription only drugs to be made available directly to the consumer without a prescription — adding more to the over-the-counter options in the healthcare aisles.

Read More

News and Updates

From the AAOA President, Matthew Ryan, MD

...the AAOA continues to be the organization that Otolaryngologists look to for up-to-date education and information on the…

read more

FDA Approves First Generic Version of EpiPen

The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr.…

read more

Social and Networking Events at the 2018 AAOA Annual Meeting

This year’s Annual Meeting assures to be not only educational, interactive, and practice-centered, but also…

read more

Menu
AAOA Logo

MIPS Practice Resources

2017 Marks Launch of New Physician Payment System

By: Erika Miller

computer-1149148_640

A new physician payment system

January 1 marked the launch of a new physician payment system, the Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).

With the launch of QPP, physicians will no longer participate in the Physician Quality Reporting System (PQRS), the Value Based Modifier, or meaningful use program.  Instead, the Merit-Based Incentive Payment System (MIPS), one of the QPP tracks, incorporates revised versions of these programs as well as a new Improvement Activities component.  Physicians who participate in an advanced alternative payment model (APM) will be exempt from MIPS.  More information on QPP and its two tracks can be found here.

When the Centers for Medicare and Medicaid Services (CMS) released its final rule implementing MACRA last fall, it included major changes from its original proposal designed to ease the burden on physicians.

For those physicians who opt to participate in MIPS, CMS is allowing physicians to pick their pace and use 2017 as a test year.  As long as physicians report one piece of quality data, they will not be subject to a penalty in 2019.  Physicians can still choose to report for the full year or some portion thereof and potentially earn a bonus.

In response to public comment, CMS further simplified the reporting options under MIPS and down weighted the cost category (formerly resource use) in 2017 since a risk adjustment methodology has not yet been finalized.  The reporting period for the advancing care information category, formerly known as meaningful use, was reduced to 90 days and its reporting requirements were simplified further.  The low-volume threshold for participation in MIPS has been raised to less than $30,000 in Medicare Fee-for-Service (FFS) revenue OR less than or equal to 100 Medicare patients, which will help provide a better safety net for small practices.

We anticipate that CMS will release another notice of proposed rulemaking this spring making further changes to the program for 2018 when we anticipate all physicians will be required to fully participate in MIPS or an advanced APM.

President Mims Message

April 2017

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

MACRA Resources

News

New Articles from IFAR

Medical therapy for Chronic Rhino-sinusitis

The indications for surgical management of chronic rhinosinusitis (CRS) in patients with cystic fibrosis (CF) are poorly defined..
Read More

Safety of long-term Intranasal Budesonide

The aim of this study was to determine the impact of long-term topical budesonide treatment via the mucosal atomization device (MAD) on the hypothalamic-pituitary-adrenal axis (HPAA) and intraocular pressure (IOP).. Read More

New Blog Posts

From the AAOA President, Matthew Ryan, MD

...the AAOA continues to be the organization that Otolaryngologists look to for up-to-date…

FDA Approves First Generic Version of EpiPen

The Food and Drug Administration approves the first generic version of…